Senti Biosciences Stock Probability of Future Stock Price Finishing Over 3.9

SNTI Stock  USD 2.18  0.01  0.46%   
Senti Biosciences' future price is the expected price of Senti Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Senti Biosciences performance during a given time horizon utilizing its historical volatility. Check out Senti Biosciences Backtesting, Senti Biosciences Valuation, Senti Biosciences Correlation, Senti Biosciences Hype Analysis, Senti Biosciences Volatility, Senti Biosciences History as well as Senti Biosciences Performance.
For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.
  
Please specify Senti Biosciences' target price for which you would like Senti Biosciences odds to be computed.

Senti Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Senti Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Senti Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Senti Biosciences generated a negative expected return over the last 90 days
Senti Biosciences has high historical volatility and very poor performance
Senti Biosciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (71.06 M) with loss before overhead, payroll, taxes, and interest of (29.78 M).
Senti Biosciences currently holds about 140.78 M in cash with (52.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Senti Biosciences has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders

Senti Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Senti Stock often depends not only on the future outlook of the current and potential Senti Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Senti Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.4 M
Cash And Short Term Investments35.9 M

Senti Biosciences Technical Analysis

Senti Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Senti Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Senti Biosciences. In general, you should focus on analyzing Senti Stock price patterns and their correlations with different microeconomic environments and drivers.

Senti Biosciences Predictive Forecast Models

Senti Biosciences' time-series forecasting models is one of many Senti Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Senti Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Senti Biosciences

Checking the ongoing alerts about Senti Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Senti Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Senti Biosciences generated a negative expected return over the last 90 days
Senti Biosciences has high historical volatility and very poor performance
Senti Biosciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (71.06 M) with loss before overhead, payroll, taxes, and interest of (29.78 M).
Senti Biosciences currently holds about 140.78 M in cash with (52.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Senti Biosciences has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders
When determining whether Senti Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Senti Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Senti Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Senti Biosciences Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.